Also trades as: STX.L (LSE) · $vol 0M
SHIEF OTC
Shield Therapeutics plc
1W: +0.0%
1M: +21.6%
3M: +7.0%
YTD: -41.4%
1Y: -15.8%
3Y: -13.5%
5Y: -93.7%
$0.09
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$7M
+76.8% ▲
Capital Expenditures
$2M
+17.9% ▲
5Y CAGR: +11.8%
Free Cash Flow
-$9M
+77.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$7M
-170.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$20M | -$40M | -$33M | -$27M |
| Depreciation & Amort. | $3M | $2M | $2M | $1M | $1M |
| Stock-Based Comp. | $1M | $992K | $754K | $686K | $860K |
| Change in Working Capital | -$547K | -$2M | $4M | -$7M | $15M |
| Other Non-Cash Items | -$7K | -$11K | -$1K | $1M | $4M |
| Operating Cash Flow | -$2M | -$17M | -$19M | -$37M | -$7M |
| — Investing Activities — | |||||
| Capital Expenditures | -$23K | -$2M | -$2M | -$187K | -$35K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $3K | $13K | $200K | -$2M | -$2M |
| Investing Cash Flow | -$20K | -$2M | -$2M | -$2M | -$2M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$48K | -$76K | $9M | $24M | $4M |
| Stock Repurchased | $0 | $0 | -$82K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$7K | -$10M | -$1M | -$1M | -$3M |
| Financing Cash Flow | -$47K | $28M | $8M | $50M | $1M |
| Net Change in Cash | -$1M | $9M | -$9M | $11M | -$7M |
| Cash End of Period | $3M | $12M | $3M | $14M | $7M |
| Free Cash Flow | -$1M | -$19M | -$20M | -$40M | -$9M |